CI 898 trihydrochloride
Unfortunately CI 898 trihydrochloride (Cat. No. 2039) was withdrawn from sale in Sep. 2016 for commercial reasons.
To view previous batch information for CI 898 trihydrochloride (Cat. No. 2039) please follow the links below:
Certificate of Analysis / Safety Data Sheet
Keywords: Dihydrofolate reductases inhibitors inhibits Antineoplastic agent affects G1/S phase progression DHFR Cell Cycle CI898 trihydrochloride
Find multiple products by catalog number
New Products in this Area
Protein disulfide isomerase (PDI) inhibitor3-AP
Ribonucleotide reductase inhibitor; also an iron chelator
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.